TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion.
Debesset A, Pilon C, Meunier S, Cuelenaere-Bonizec O, Richer W, Thiolat A, Houppe C, Ponzo M, Magnan J, Caron J, Caudana P, Tosello Boari J, Baulande S, To NH, Salomon BL, Piaggio E, Cascone I, Cohen JL.
Debesset A, et al. Among authors: to nh.
J Immunother Cancer. 2024 Nov 19;12(11):e008898. doi: 10.1136/jitc-2024-008898.
J Immunother Cancer. 2024.
PMID: 39562007
Free PMC article.